REFRACTORY FORM OF GASTROESOPHAGEAL REFLUX DISEASE: EVOLUTION OF CONCEPTS
- Authors: Davydkin I.L1, Osadchuk A.M1, Gritsenko T.A1, Kurtov I.V1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 2, No 1 (2017)
- Pages: 24-30
- Section: Articles
- URL: https://bakhtiniada.ru/2500-1388/article/view/21513
- DOI: https://doi.org/10.35693/2500-1388-2017-0-1-24-30
- ID: 21513
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
IL L Davydkin
Samara State Medical University
Email: dagi2006@rambler.ru
PhD, Professor, head of the Department of hospital therapy with courses of outpatient therapy and transfusiology, Samara State Medical University
AM M Osadchuk
Samara State Medical University
Email: maxlife2004@mail.ru
PhD, professor of the Department of hospital therapy with courses of outpatient therapy and transfusiology, Samara State Medical University. ap.157, 48 Agibalova st Samara, Russia, 443041
TA A Gritsenko
Samara State Medical University
Email: taras876@mail.ru
PhD, associate professor of the Department of hospital therapy with courses of outpatient therapy and transfusiology of Samara State Medical University, hematologist of the 1st Hematology department of the Clinics of Samara State Medical University
IV V Kurtov
Samara State Medical University
Email: sam-med@mail.ru
PhD, head of the 1st Hematology department of the Clinics of Samara State Medical University, associate professor of the Department of hospital therapy with courses of outpatient therapy and transfusiology of Samara State Medical
References
- Старостин Б.Д. Гастроэзофагеальная рефлюксная болезнь (часть I). Эпидемиология, факторы риска. Гастроэнтерология Санкт-Петербурга. 2014;1(2):2-14
- Sifrim D. Acid, weakly acidic and non-acid gastro-oesophageal reflux. Eur JGastroenterolHepatol. 2004(16):823-830. doi.org/10.1097/00042737-200409000-00002
- Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep. 2008(10):252-257. doi.org/10.1007/s11894-008-0052-5
- Sharma N, Agrawal A, Freeman J. et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008;6:521-524. doi.org/10.1016/j.cgh.2008.01.006
- Aziz Q, Fass R, Gyawali CP. et al. Esophageal disoders. Gastroenterology. 2016(150):1368-1379. doi.org/10.1053/j. gastro.2016.02.012
- Shapiro M, Green C, Bautista JM. et al. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am JGastroenterol. 2006(101):1084-1091. doi.org/10.1111/j.1572-0241.2006.00525.x
- Yoshida N, Kuroda M, Suzuki T. et al. Role of nociceptors/ neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease. Dig. Dis. Sci. 2012(58):2237-2243. doi.org/10.1007/s10620-012-2337-7
- Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009(58):295-309. doi.org/10.1136/ gut.2007.145581
- Todd JA, Basu KK, de Caestecker JS. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther. 2005;21:969-975. doi.org/10.1111/j.1365-2036.2005.02406.x
- Farre R, Van Malenstein MH, de Vos R, et al. Weakly acidic solutions containing pepsin and bile acids can increase significantly esophageal mucosa permeability (abstract). Gastroenterology. 2007;132(4 Suppl 2):S1897
- Peghini PL, Katz PO, Bracy NA. et al. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am JGastroenterol. 1998(93):763-767. doi. org/10.1111/j.1572-0241.1998.221_a.x
- Dammann HG, Fuchs W, Richter G. et al. Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. Aliment Pharmacol Ther. 1997(11):359-364. doi. org/10.1046/j.1365-2036.1997.157332000.x
- Leite L, Lambrecht N, Sachs G. et al. Is omeprazole resistance due to mutations of cysteine 813 or 822 in the acid pump? (abstract). Gastroenterology. 1995;108:A147
- Chiba N., De Gara C.J., Wilkinson J.M. et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997(112):1798-1810. doi.org/10.1053/gast.1997.v112.pm9178669
- Давыдкин И.Л. Осадчук А.М. Бородулина Е.А. Гриценко Т.А. Инфильтративный туберкулез легких, язвенная болезнь и ВИЧ-инфекция (коморбидность и мультиморбидность заболеваний). Наука и инновации в медицине. 2016(1):19-24
- Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology. 1999(117):11-16. doi.org/10.1016/s0016-5085(99)70544-5
- Mizyed I, Fass SS, Fass R. Review article: gastro-oesophageal reflux disease and psychological comorbidity. Aliment Pharmacol Ther. 2009(29):351-358. doi.org/10.1111/ j.1365-2036.2008.03883.x
- Rohof WO, Bennink RJ, de Jonge H. et al. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2014(12):1647-1655. doi.org/10.1016/j.cgh.2013.10.026
- Осадчук М.А., Осадчук А.М., Балашов Д.В., Кветной ИМ. Рефрактерная форма гастроэзофагеальной рефлюксной болезни: клинико-эндоскопические, функциональные и морфофункциональные критерии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2011(2):30-37
- Гриценко ТА., Давыдкин И.Л., Осадчук А.М., Косталанова Ю.В. Гастроэзофагеальная рефлюксная болезнь у пациентов, получающих полихимиотерапию: клинические, эндоскопические, морфологические и иммуногистохимические особенности. Экспериментальная и клиническая гастроэнтерология. 2015;2(114):17-23
- Becker V. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors. World JGastroenterol. 2014(20):4017-4024. doi.org/10.3748/ wjg.v20.i14.4017
- Хуболов А.М., Толстокоров А.С., Коваленко Ю.В. Результаты антирефлюксной хирургической коррекции грыж пищеводного отверстия диафрагмы у лиц пожилого и старческого возраста. Аспирантский вестник Поволжья. 2016; 1(2): 167-171
- Chowers Y, Atarot T, Pratha VS. et al. The effect of once daily omeprazole and succinic acid (VECAM) vs. once daily omeprazole on 24-h intragastric pH. Neurogastroenterol Motil. 2012 (24):426-431. doi.org/10.1111/j.1365-2982.2012.01884
- Vela MF, Tutuian R, Katz P.O. et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment PharmacolTher. 2003(17):243-251. doi. org/10.1046/j.1365-2036.2003.01394.x
- Adachi K, Furuta K, Miwa H. et al. A study on the efficacy of rebamipide for patients with proton pump inhibitor-refractory non-erosive reflux disease. Dig Dis Sci. 2012(57):1609-1617. doi.org/10.1007/s10620-012-2087-6
- Maradey-Romero C, Fass R. New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2014(20):6-16. doi.org/10.5056/ jnm.2014.20.1.6
Supplementary files
